Delhi HC allows Alembic, Natco to export Bayer drug for specific purposes

- HC allows Alembic and Natco Pharma to export cancer drug and a blood thinner for development, clinical trials and regulatory clearances
- The ruling came on two pleas filed by Bayer, which had moved against Natco and Alembic for export of a cancer drug and a blood thinner, respectively